As of Nov 25
| +0.42 / +1.03%|
The 29 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 44.02, with a high estimate of 54.00 and a low estimate of 34.89. The median estimate represents a +6.92% increase from the last price of 41.17.
The current consensus among 32 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.